This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

No Significant Event

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 05/30/2023
Location: Silver Spring, MD
Subject: African Medicines Agency Meeting
FDA Participant/Group: ELLEN HART; THERESA MULLIN; ANNA FERUS; SEMA HASHEMI; GOPA RAYCHAUDHURI; NEIL MAFNAS; C MICHELLE LIMOLI; HARINDER CHAHAL; STEPHANIE SHEDD; SEGARAN PILLAI; KRISTAN CALLAHAN; MARK ABDOO; ERIN CUTTS; RAVI BHARWANI; MELISSA TORRES; MICHELLE NOONAN; JUDITH BADOO; DOUGLAS SHAFFER;
Non FDA Participant/Group: Alex Ismail, Chimwemwe Chamdimba (African Union Development Agency); Moustapha Zakari (African Union Commission); Emile Bienvenu, Patrick Rugambya (Government of Rwanda); Alexander Tetradze, Mikolaj Korzistka, Terasita Bernales (U.S. Department of State); Julius Otim (East African Community); Shingai Machingaidze, Yenew Tebeje (Africa Centres for Disease Control and Prevention (CDC));

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 06/01/2023
Location: Washington, D.C.
Subject: International Bar Association's World Life Sciences Conference; Speaker: FDA In the World
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, advocacy, government, and other stakeholders

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 05/30/2023
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Shingai Machingaidze (Africa Centres for Disease Control and Prevention (CDC));

Event Date: 05/30/2023
Location: Virtual
Subject: FDA / American Society for Clinical Pharmacology and Therapeutics (ASPT) Annual Abrams Lecture; Speaker: Mechanistic Studies in Drug Metabolism and Single Cell Biology to Advance Clinical Pharmacology
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 06/02/2023
Location: Virtual
Subject: Global CEO Initiative (CEOi) on Alzheimer’s Disease; Vaccines Roadmap Workgroup Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event